EMERGENT BIOSOLUTIONS INC (EBS)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for EBS
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| EBS | Director; Chairman of the Board | 82 | ["Chairman of the Board of N-Gene Research Laboratories, Inc.", "Chief Executive Officer and Chairman of the Board of Directors of Expo Bio Inc.", "Director of Aptevo Therapeutics Inc.", "President of Porton International plc", "Founder of Dynport Vaccine Company LLC", "Vice president of corporate finance at E.F. Hutton, Inc.", "Directed the first assessment of biotechnology for the U.S. Congress\u2019 Office of Technology Assessment", "Consultant to the Presidents\u2019 Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research", "Faculty of Microbiology and Genetics at Cornell Medical College", "Ph.D. from Albert Einstein College of Medicine", "B.A. from Amherst College"] | ["Audit and Finance", "Scientific Review", "Quality, Compliance, Manufacturing and Risk Management"] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Harsanyi has served as the Chairman of our Board of Directors since April 2022 and as a director since August 2004. Dr. Harsanyi has also served as Chairman of the Board of N-Gene Research Laboratories, Inc., a privately-held biopharmaceutical company. Prior to that, Dr. Harsanyi served as Chief Executive Officer and Chairman of the Board of Directors of Expo Bio Inc., ( ExpoBio ), a private biotechnology company, from December 2004 to February 2011. In January 2016, Dr. Harsanyi returned to ExpoBio to serve as Chairman of the board. Since August 2016, Dr. Harsanyi has been a director of Aptevo Therapeutics Inc., ( Aptevo ) a publicly-traded biotech company which focuses on bringing novel oncology and hematology therapeutics to market. Dr. Harsanyi served as president of Porton International plc, a pharmaceutical and vaccine company, from January 1983 to December 2004. Dr. Harsanyi was a founder of Dynport Vaccine Company LLC in September 1996. Prior to joining Porton International, Dr. Harsanyi was vice president of corporate finance at E.F. Hutton, Inc. Previously, Dr. Harsanyi directed the first assessment of biotechnology for the U.S. Congress Office of Technology Assessment, served as a consultant to the Presidents Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research and was on the faculties of Microbiology and Genetics at Cornell Medical College. Dr. Harsanyi received a Ph.D. from Albert Einstein College of Medicine and a B.A. from Amherst College. Qualifications: We believe Dr. Harsanyi s qualifications to serve on our Board of Directors include his industry experience, including his senior executive and financial positions.